Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Fig. 1

Relative HOXD-AS1 expression level in bladder cancer tissues and cells. a A total of 50 bladder cancer patients included in this study were divided into two groups: the relative low expression group (n = 20) and the relative high expression group (n = 30). b HOXD-AS1 was up-regulated in bladder cancer tissues compare to matched non tumor tissues (P = 0.002). c, d HOXD-AS1 expression level were higher in 5637 (P < 0.001) and T24 cells (P = 0.001) than normal human bladder epithelial cells (SV-HUC1)

Back to article page